_________
false
אקס טי אל ביופרמסוטיקלס בע"מ
2
381
X T L BIOPHARMACEUTICALS LTD
Corporation no:
520039470
4313
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
02/06/2021
www.isa.gov.il
www.tase.co.il
Reference:
2021-02-034834
Time of broadcast:
21:09
21:09
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Post Effective Amendment No.1 to Form F-1 on Form F-3
ea141785-posama1_xtlbiophar_bannerless_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
04/05/2021
Address:
HaCharoshet st
5
,
Ra'anana
43656
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E-mail address:
ir@xtlbio.com
Company site:
www.xtlbio.com
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Name of the Signatory:
Kntor Ronen
Position of Signatory in the reporting corporation:
Attorney/Legal Counsel
Name of Employer Company:
Address:
abba hillel
12
,
ramat gan
5250606
Telephone:
03-6133371
Facsimile:
03-6133372
E-mail:
rkantor@dtkgc.com
1